Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 4-bromo-2,6-dimethoxy- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61203-54-1

Post Buying Request

61203-54-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61203-54-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61203-54-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,2,0 and 3 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 61203-54:
(7*6)+(6*1)+(5*2)+(4*0)+(3*3)+(2*5)+(1*4)=81
81 % 10 = 1
So 61203-54-1 is a valid CAS Registry Number.

61203-54-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-bromo-2,6-dimethoxybenzoic acid

1.2 Other means of identification

Product number -
Other names 4-Brom-2,6-dimethoxy-benzoesaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61203-54-1 SDS

61203-54-1Relevant academic research and scientific papers

SALT INDUCIBLE KINASE INHIBITORS

-

, (2022/02/15)

The present application provides compounds that modulate the activity of one or more salt inducible kinases (SIKs). Pharmaceutical composition and methods of treating diseases associated with abnormal expression and/or activity of one or more SIKs are also provided.

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

-

Page/Page column 384-385, (2021/09/11)

BRD9 protein degradation compounds or pharmaceutically acceptable salts thereof are provided for the treatment of disorders mediated by BRD9, including but not limited to abnormal cellular proliferation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61203-54-1